Increased PKR expression has been shown to correlate with better prognoses in head and neck cancer and colon cancer [2], [3], and accumulating evidence demonstrates that PKR may act as a tumor suppressor in leukemia and other hematopoietic malignancies [4], [5]. The gene discussed is EIF2AK2; the disease is neoplasm.